210 related articles for article (PubMed ID: 33603167)
1. Porcine model elucidates function of p53 isoform in carcinogenesis and reveals novel circTP53 RNA.
Niu G; Hellmuth I; Flisikowska T; Pausch H; Rieblinger B; Carrapeiro A; Schade B; Böhm B; Kappe E; Fischer K; Klinger B; Steiger K; Burgkart R; Bourdon JC; Saur D; Kind A; Schnieke A; Flisikowski K
Oncogene; 2021 Mar; 40(10):1896-1908. PubMed ID: 33603167
[TBL] [Abstract][Full Text] [Related]
2. Development and translational imaging of a TP53 porcine tumorigenesis model.
Sieren JC; Meyerholz DK; Wang XJ; Davis BT; Newell JD; Hammond E; Rohret JA; Rohret FA; Struzynski JT; Goeken JA; Naumann PW; Leidinger MR; Taghiyev A; Van Rheeden R; Hagen J; Darbro BW; Quelle DE; Rogers CS
J Clin Invest; 2014 Sep; 124(9):4052-66. PubMed ID: 25105366
[TBL] [Abstract][Full Text] [Related]
3. Inactivation and inducible oncogenic mutation of p53 in gene targeted pigs.
Leuchs S; Saalfrank A; Merkl C; Flisikowska T; Edlinger M; Durkovic M; Rezaei N; Kurome M; Zakhartchenko V; Kessler B; Flisikowski K; Kind A; Wolf E; Schnieke A
PLoS One; 2012; 7(10):e43323. PubMed ID: 23071491
[TBL] [Abstract][Full Text] [Related]
4. Damage-inducible intragenic demethylation of the human TP53 tumor suppressor gene is associated with transcription from an alternative intronic promoter.
Blackburn J; Roden DL; Ng R; Wu J; Bosman A; Epstein RJ
Mol Carcinog; 2016 Dec; 55(12):1940-1951. PubMed ID: 26676339
[TBL] [Abstract][Full Text] [Related]
5. Cancer-specific mutations in p53 induce the translation of Δ160p53 promoting tumorigenesis.
Candeias MM; Hagiwara M; Matsuda M
EMBO Rep; 2016 Nov; 17(11):1542-1551. PubMed ID: 27702985
[TBL] [Abstract][Full Text] [Related]
6. TP53 isoform junction reads based analysis in malignant and normal contexts.
Vural S; Chang LC; Yee LM; Sonkin D
Sci Rep; 2021 Aug; 11(1):17275. PubMed ID: 34446762
[TBL] [Abstract][Full Text] [Related]
7. P63 modulates the expression of the WDFY2 gene which is implicated in cancer regulation and limb development.
Monti P; Ciribilli Y; Foggetti G; Menichini P; Bisio A; Cappato S; Inga A; Divizia MT; Lerone M; Bocciardi R; Fronza G
Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31789342
[TBL] [Abstract][Full Text] [Related]
8. Diverse p63 and p73 isoforms regulate Δ133p53 expression through modulation of the internal TP53 promoter activity.
Marcel V; Petit I; Murray-Zmijewski F; Goullet de Rugy T; Fernandes K; Meuray V; Diot A; Lane DP; Aberdam D; Bourdon JC
Cell Death Differ; 2012 May; 19(5):816-26. PubMed ID: 22075982
[TBL] [Abstract][Full Text] [Related]
9. Biological functions of p53 isoforms through evolution: lessons from animal and cellular models.
Marcel V; Dichtel-Danjoy ML; Sagne C; Hafsi H; Ma D; Ortiz-Cuaran S; Olivier M; Hall J; Mollereau B; Hainaut P; Bourdon JC
Cell Death Differ; 2011 Dec; 18(12):1815-24. PubMed ID: 21941372
[TBL] [Abstract][Full Text] [Related]
10. Generation of a TP53-modified porcine cancer model by CRISPR/Cas9-mediated gene modification in porcine zygotes via electroporation.
Tanihara F; Hirata M; Nguyen NT; Le QA; Hirano T; Takemoto T; Nakai M; Fuchimoto DI; Otoi T
PLoS One; 2018; 13(10):e0206360. PubMed ID: 30352075
[TBL] [Abstract][Full Text] [Related]
11. CircTP53 promotes the proliferation of thyroid cancer via targeting miR-1233-3p/MDM2 axis.
Ma W; Zhao P; Zang L; Zhang K; Liao H; Hu Z
J Endocrinol Invest; 2021 Feb; 44(2):353-362. PubMed ID: 32500444
[TBL] [Abstract][Full Text] [Related]
12. p53 Dysregulation in Breast Cancer: Insights on Mutations in the
Steffens Reinhardt L; Groen K; Xavier A; Avery-Kiejda KA
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373225
[TBL] [Abstract][Full Text] [Related]
13. Impact of G-quadruplex structures and intronic polymorphisms rs17878362 and rs1642785 on basal and ionizing radiation-induced expression of alternative p53 transcripts.
Perriaud L; Marcel V; Sagne C; Favaudon V; Guédin A; De Rache A; Guetta C; Hamon F; Teulade-Fichou MP; Hainaut P; Mergny JL; Hall J
Carcinogenesis; 2014 Dec; 35(12):2706-15. PubMed ID: 25269805
[TBL] [Abstract][Full Text] [Related]
14.
Watanabe S; Tsuchiya K; Nishimura R; Shirasaki T; Katsukura N; Hibiya S; Okamoto R; Nakamura T; Watanabe M
Mol Cancer Res; 2019 Jul; 17(7):1459-1467. PubMed ID: 30988165
[TBL] [Abstract][Full Text] [Related]
15. Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo.
Concin N; Becker K; Slade N; Erster S; Mueller-Holzner E; Ulmer H; Daxenbichler G; Zeimet A; Zeillinger R; Marth C; Moll UM
Cancer Res; 2004 Apr; 64(7):2449-60. PubMed ID: 15059898
[TBL] [Abstract][Full Text] [Related]
16. A novel loss-of-function mutation in TP53 in an endometrial cancer cell line and uterine papillary serous carcinoma model.
Liu Z; Wan G; Heaphy C; Bisoffi M; Griffith JK; Hu CA
Mol Cell Biochem; 2007 Mar; 297(1-2):179-87. PubMed ID: 17119852
[TBL] [Abstract][Full Text] [Related]
17. Mutant p53
Polireddy K; Singh K; Pruski M; Jones NC; Manisundaram NV; Ponnela P; Ouellette M; Van Buren G; Younes M; Bynon JS; Dar WA; Bailey JM
Cancer Lett; 2019 Jul; 453():122-130. PubMed ID: 30946870
[TBL] [Abstract][Full Text] [Related]
18. Effects of TP53 mutational status on gene expression patterns across 10 human cancer types.
Parikh N; Hilsenbeck S; Creighton CJ; Dayaram T; Shuck R; Shinbrot E; Xi L; Gibbs RA; Wheeler DA; Donehower LA
J Pathol; 2014 Apr; 232(5):522-33. PubMed ID: 24374933
[TBL] [Abstract][Full Text] [Related]
19. Translation of human Δ133p53 mRNA and its targeting by antisense oligonucleotides complementary to the 5'-terminal region of this mRNA.
Żydowicz-Machtel P; Dutkiewicz M; Swiatkowska A; Gurda-Woźna D; Ciesiołka J
PLoS One; 2021; 16(9):e0256938. PubMed ID: 34492050
[TBL] [Abstract][Full Text] [Related]
20. G-quadruplex structures in TP53 intron 3: role in alternative splicing and in production of p53 mRNA isoforms.
Marcel V; Tran PL; Sagne C; Martel-Planche G; Vaslin L; Teulade-Fichou MP; Hall J; Mergny JL; Hainaut P; Van Dyck E
Carcinogenesis; 2011 Mar; 32(3):271-8. PubMed ID: 21112961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]